Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultrashort Regimen for Drug-susceptible Pulmonary Tuberculosis in Elderly Patients
NCT07076225Phase 3Not yet recruiting
- Sponsor
- Shenzhen Third People's Hospital
- Start
- Jul 2025
- Primary completion
- Jan 2030
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of bedaquiline, linezolid, sitafloxacin in pulmonary tuberculosis (TB), sponsored by Shenzhen Third People's Hospital. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
bedaquilinelinezolidsitafloxacin
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NCT07076225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07076225.